drugset

drugset / Trial / NCT03010787

A First Time in Human Study in Healthy Volunteers and Patients

NCT03010787 ↗

Phase 1 Completed 47 enrolled VHsquared Ltd.

RandomizedParallel-groupDouble-blind

Summary

A multi-part study to investigate the safety, tolerability and local and systemic pharmacokinetics of V565

Timeline

Start: 2015-09
Primary completion: 2016-03
Completion: 2016-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	V565	Protein / enzyme biologic	—	Oral

Indications